Key statistics
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 6.20 |
---|---|
High | 6.55 |
Low | 6.20 |
Bid | 6.75 |
Offer | 6.90 |
Previous close | 6.60 |
Average volume | 3.58k |
---|---|
Shares outstanding | 77.18m |
Free float | 45.94m |
P/E (TTM) | -- |
Market cap | 514.05m USD |
EPS (TTM) | -1.49 USD |
Data delayed at least 15 minutes, as of Nov 13 2024 14:34 GMT.
More ▼
Announcements
- MeiraGTx Announces Third Quarter 2024 Financial and Operational Results and Recent Business Updates
- MeiraGTx Announces Five Posters at the European Society of Gene and Cell Therapy (ESGCT) 2024 Annual Congress
- MeiraGTx Announces Positive Data from Randomized, Sham-controlled Clinical Bridging Study of AAV-GAD for the Treatment of Parkinson’s Disease
- MeiraGTx Announces Poster Presentation on a Potential Treatment for MC4R Genetic Deficiency at the 2024 Society for Neuroscience Conference
- MeiraGTx Announces $50 Million Offering of Ordinary Shares led by Sanofi and Reports Second Quarter 2024 Financial and Operational Results
- MeiraGTx Announces Pricing of Offering of Ordinary Shares Led by Sanofi
- MeiraGTx Reports First Quarter 2024 Financial and Operational Results
- MeiraGTx to Participate in Upcoming Investor Conferences
- MeiraGTx Announces Oral Presentation at the 2024 American Academy of Oral Medicine (AAOM) Annual Conference
- MeiraGTx Reports Fourth Quarter and Full Year 2023 Financial and Operational Results and Recent Business Updates
More ▼